PP
PIROUETTE PHARMA INC.
SEC filingPharmaceuticals · Portsmouth, NH
Amount raised$1.1Msold at filing
Total offering$6M$4.9M still open
Investors in the raise1count reported to the SEC
FiledMar 18, 2026first sale Mar 10, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
JOSEPH NEMMERSDirector
PARINAZ MOTAMEDYDirector
MATTHEW KANEExecutive Officer, Director, Promoter
ELIJAH KAPASExecutive Officer, Promoter
CONOR CULLINANEExecutive Officer, Director, Promoter
Executive officers, directors and promoters as listed on the Form D.